Literature DB >> 11136767

Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand.

D Girlich1, L Poirel, A Leelaporn, A Karim, C Tribuddharat, M Fennewald, P Nordmann.   

Abstract

Over a 21/2-month period in 1999, 37 ceftazidime-resistant nonrepetitive enterobacterial isolates were collected from 37 patients in a Bangkok hospital, Thailand. Eighty-one percent of these strains expressed a clavulanic acid-inhibited extended-cephalosporin resistance profile. An identical extended-spectrum beta-lactamase (ESBL), VEB-1, was found in 16 unrelated enterobacterial isolates (Escherichia coli, n = 10; Enterobacter cloacae, n = 2; Enterobacter sakazakii, n = 1; and Klebsiella pneumoniae, n = 3) and in two clonally related E. cloacae isolates. The bla(VEB-1) gene was located on mostly self-conjugative plasmids (ca. 24 to 200 kb) that conferred additional non-beta-lactam antibiotic resistance patterns. Additionally, the bla(VEB-1) gene cassette was part of class 1 integrons varying in size and structure. The bla(VEB-1)-containing integrons were mostly associated with bla(OXA-10)-like and arr-2-like gene cassettes, the latter conferring resistance to rifampin. These data indicated the spread of bla(VEB-1) in Bangkok due to frequent transfer of different plasmids and class 1 integrons and rarely to clonally related strains. Plasmid- and integron-mediated resistance to rifampin was also found in enterobacterial isolates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136767      PMCID: PMC87698          DOI: 10.1128/JCM.39.1.175-182.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.

Authors:  L Poirel; I Le Thomas; T Naas; A Karim; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.

Authors:  E Tzelepi; P Giakkoupi; D Sofianou; V Loukova; A Kemeroglou; A Tsakris
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Distribution and content of class 1 integrons in different Vibrio cholerae O-serotype strains isolated in Thailand.

Authors:  A Dalsgaard; A Forslund; O Serichantalergs; D Sandvang
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

4.  A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan.

Authors:  T Yagi; H Kurokawa; N Shibata; K Shibayama; Y Arakawa
Journal:  FEMS Microbiol Lett       Date:  2000-03-01       Impact factor: 2.742

Review 5.  OXA-type beta-lactamases.

Authors:  T Naas; P Nordmann
Journal:  Curr Pharm Des       Date:  1999-11       Impact factor: 3.116

6.  In vitro evaluation of cefepime and other broad-spectrum beta-lactams in eight medical centers in Thailand. The Thailand Antimicrobial Resistance Study Group.

Authors:  D J Biedenbach; D M Johnson; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1999-12       Impact factor: 2.803

7.  Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut.

Authors:  F C Tenover; M J Mohammed; T S Gorton; Z F Dembek
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

8.  Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan.

Authors:  J J Yan; S M Wu; S H Tsai; J J Wu; I J Su
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

9.  Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Authors:  L Poirel; T Naas; D Nicolas; L Collet; S Bellais; J D Cavallo; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

10.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

View more
  59 in total

1.  Plasmid-mediated rifampin resistance encoded by an arr-2-like gene cassette in Klebsiella pneumoniae producing an ACC-1 class C beta-lactamase.

Authors:  G Arlet; D Nadjar; J L Herrmann; J L Donay; P H Lagrange; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

2.  Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001.

Authors:  J M Bell; J D Turnidge; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 3.  Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact.

Authors:  Gerhard F Weldhagen; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

4.  Group IIC intron with an unusual target of integration in Enterobacter cloacae.

Authors:  José-Manuel Rodríguez-Martínez; Patrice Nordmann; Laurent Poirel
Journal:  J Bacteriol       Date:  2011-10-21       Impact factor: 3.490

5.  Extended-spectrum-β-lactamase-producing Enterobacteriaceae isolated from vegetables imported from the Dominican Republic, India, Thailand, and Vietnam.

Authors:  Katrin Zurfluh; Magdalena Nüesch-Inderbinen; Marina Morach; Annina Zihler Berner; Herbert Hächler; Roger Stephan
Journal:  Appl Environ Microbiol       Date:  2015-02-27       Impact factor: 4.792

6.  Novel Ambler class A beta-lactamase LAP-1 and its association with the plasmid-mediated quinolone resistance determinant QnrS1.

Authors:  Laurent Poirel; Vincent Cattoir; Ana Soares; Claude-James Soussy; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

7.  Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.

Authors:  Jacob Schlesinger; Shiri Navon-Venezia; Inna Chmelnitsky; Orly Hammer-Münz; Azita Leavitt; Howard S Gold; Mitchell J Schwaber; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

8.  Association of plasmid-mediated quinolone resistance with extended-spectrum beta-lactamase VEB-1.

Authors:  Laurent Poirel; Marc Van De Loo; Hedi Mammeri; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

9.  Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa.

Authors:  A Deplano; O Denis; L Poirel; D Hocquet; C Nonhoff; B Byl; P Nordmann; J L Vincent; M J Struelens
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

10.  Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.

Authors:  Dongeun Yong; Mark A Toleman; Christian G Giske; Hyun S Cho; Kristina Sundman; Kyungwon Lee; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.